Related Experiment Video
Updated: May 10, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
Functional domains of androgen receptor coactivator p44/Mep50/WDR77and its interaction with Smad1
Yirong Li1, Liantian Tian, Martin Ligr
1Department of Pathology, New York University School of Medicine, New York, New York, USA.
Abstract:
p44/MEP50/WDR77 has been identified as a coactivator of androgen receptor (AR), with distinct growth suppression and promotion function in gender specific endocrine organs and their malignancies. We dissected the functional domains of p44 for protein interaction with transcription factors, transcriptional activation, as well as the functional domains in p44 related to its growth inhibition in prostate cancer. Using a yeast two-hybrid screen, we identified a novel transcription complex AR-p44-Smad1, confirmed for physical interaction by co-immunoprecipitaion and functional interaction with luciferase assays in human prostate cancer cells. Yeast two-hybrid assay revealed that the N-terminal region of p44, instead of the traditional WD40 domain at the C-terminus, mediates the interaction among p44, N-terminus of AR and full length Smad1. Although both N and C terminal domains of p44 are necessary for maximum AR transcriptional activation, the N terminal fragment of p44 alone maintains the basic effect on AR transcriptional activation. Cell proliferation assays with N- and C- terminal deletion mutations indicated that the central portion of p44 is required for nuclear p44 mediated prostate cancer growth inhibition.
Insights
The p44 protein interacts with the androgen receptor (AR) and Smad1, forming a novel transcription complex. Its N-terminal region is crucial for this interaction and prostate cancer growth inhibition.
Area of Science:
- Molecular biology
- Endocrinology
- Cancer research
Background:
- p44 (also known as MEP50/WDR77) acts as a coactivator for the androgen receptor (AR).
- p44 exhibits distinct functions in promoting or suppressing growth in endocrine organs and associated cancers.
Purpose of the Study:
- To dissect the functional domains of p44.
- To identify p44's role in protein interactions with transcription factors.
- To understand p44's transcriptional activation and growth inhibition functions in prostate cancer.
Main Methods:
- Yeast two-hybrid screening to identify interacting proteins.
- Co-immunoprecipitation to confirm physical interactions.
- Luciferase assays to assess functional interactions in human prostate cancer cells.
- Cell proliferation assays using deletion mutants of p44.
Main Results:
- A novel transcription complex, AR-p44-Smad1, was identified and confirmed.
- The N-terminal region of p44, not the C-terminal WD40 domain, mediates interaction with AR and Smad1.
- Both N- and C-terminal domains of p44 are needed for maximal AR transcriptional activation, but the N-terminus alone supports basic activation.
- The central portion of p44 is essential for its role in inhibiting prostate cancer cell growth.
Conclusions:
- p44 interacts with AR and Smad1 via its N-terminal region, forming a functional transcription complex.
- p44's central domain is critical for mediating its growth-inhibitory effects in prostate cancer.
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Master Transcription Regulators
Co-activators and Co-repressors
Co-activators and Co-repressors
TGF - β Signaling Pathway
MAPK Signaling Cascades

